291 related articles for article (PubMed ID: 35296731)
41. Regulation of cardiac O-GlcNAcylation: More than just nutrient availability.
Collins HE; Chatham JC
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165712. PubMed ID: 32014551
[TBL] [Abstract][Full Text] [Related]
42. O-GlcNAc modification, insulin signaling and diabetic complications.
Issad T; Masson E; Pagesy P
Diabetes Metab; 2010 Dec; 36(6 Pt 1):423-35. PubMed ID: 21074472
[TBL] [Abstract][Full Text] [Related]
43. Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain.
Förster S; Welleford AS; Triplett JC; Sultana R; Schmitz B; Butterfield DA
Biochim Biophys Acta; 2014 Sep; 1842(9):1333-9. PubMed ID: 24859566
[TBL] [Abstract][Full Text] [Related]
44. Foetal recapitulation of nutrient surplus signalling by O-GlcNAcylation and the failing heart.
Packer M
Eur J Heart Fail; 2023 Aug; 25(8):1199-1212. PubMed ID: 37434410
[TBL] [Abstract][Full Text] [Related]
45. O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy.
Xu C; Liu G; Liu X; Wang F
Int J Mol Med; 2014 Mar; 33(3):624-32. PubMed ID: 24366041
[TBL] [Abstract][Full Text] [Related]
46. Cross regulation between mTOR signaling and O-GlcNAcylation.
Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
[TBL] [Abstract][Full Text] [Related]
47. O-GlcNAcylation of the human epidermal growth factor receptor.
Stateva SR; Villalobo A
Org Biomol Chem; 2015 Aug; 13(30):8196-204. PubMed ID: 26108188
[TBL] [Abstract][Full Text] [Related]
48. Sustained
Tan EP; McGreal SR; Graw S; Tessman R; Koppel SJ; Dhakal P; Zhang Z; Machacek M; Zachara NE; Koestler DC; Peterson KR; Thyfault JP; Swerdlow RH; Krishnamurthy P; DiTacchio L; Apte U; Slawson C
J Biol Chem; 2017 Sep; 292(36):14940-14962. PubMed ID: 28739801
[TBL] [Abstract][Full Text] [Related]
49.
Xu Z; Isaji T; Fukuda T; Wang Y; Gu J
J Biol Chem; 2019 Mar; 294(9):3117-3124. PubMed ID: 30587575
[No Abstract] [Full Text] [Related]
50. Yeast cells as an assay system for in vivo O-GlcNAc modification.
Nakanishi H; Li F; Han B; Arai S; Gao XD
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1159-1167. PubMed ID: 28263870
[TBL] [Abstract][Full Text] [Related]
51. RNA binding motif protein 3 (RBM3) promotes protein kinase B (AKT) activation to enhance glucose metabolism and reduce apoptosis in skeletal muscle of mice under acute cold exposure.
Liu Y; Shi H; Hu Y; Yao R; Liu P; Yang Y; Li S
Cell Stress Chaperones; 2022 Nov; 27(6):603-618. PubMed ID: 36149580
[TBL] [Abstract][Full Text] [Related]
52. Regulation of Dauer formation by O-GlcNAcylation in Caenorhabditis elegans.
Lee J; Kim KY; Lee J; Paik YK
J Biol Chem; 2010 Jan; 285(5):2930-9. PubMed ID: 19940149
[TBL] [Abstract][Full Text] [Related]
53. '
Zhao L; Shah JA; Cai Y; Jin J
Molecules; 2018 Aug; 23(8):. PubMed ID: 30082668
[TBL] [Abstract][Full Text] [Related]
54. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
[TBL] [Abstract][Full Text] [Related]
55. Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease.
Tramutola A; Sharma N; Barone E; Lanzillotta C; Castellani A; Iavarone F; Vincenzoni F; Castagnola M; Butterfield DA; Gaetani S; Cassano T; Perluigi M; Di Domenico F
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3309-3321. PubMed ID: 30031227
[TBL] [Abstract][Full Text] [Related]
56. O-GlcNAcylation regulates extracellular signal-regulated kinase (ERK) activation in Alzheimer's disease.
Ephrame SJ; Cork GK; Marshall V; Johnston MA; Shawa J; Alghusen I; Qiang A; Denson AR; Carman MS; Fedosyuk H; Swerdlow RH; Slawson C
Front Aging Neurosci; 2023; 15():1155630. PubMed ID: 37469955
[TBL] [Abstract][Full Text] [Related]
57. Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation.
Sunden M; Upadhyay D; Banerjee R; Sipari N; Fellman V; Kallijärvi J; Purhonen J
Cell Rep Methods; 2023 Jul; 3(7):100518. PubMed ID: 37533645
[TBL] [Abstract][Full Text] [Related]
58. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
59. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
[TBL] [Abstract][Full Text] [Related]
60. O-GlcNAcylation in Renal (Patho)Physiology.
Silva-Aguiar RP; Peruchetti DB; Pinheiro AAS; Caruso-Neves C; Dias WB
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
